Literature DB >> 23670263

[Molecular diagnostics in pathology].

A Stenzinger1, R Penzel, V Endris, W Weichert.   

Abstract

Tissue-based molecular diagnostics is a fast growing diagnostic field, which already complements morphologic classifications in many cases. Pathology based molecular diagnosis is performed almost exclusively on paraffin embedded material and always in conjunction with histopathology. Besides the classic field of tissue based detection of pathogenic organisms such as bacteria, viruses and fungi, molecular diagnostics of tumor tissue is one of the current hot topics in oncology. In this context the detection of predictive molecular biomarkers, such as specific mutations, allows patient stratification for individually tailored treatment strategies and thereby is one of the key components of individualized patient care in oncology. The rapidly growing number of clinically relevant predictive biomarkers together with impressive technical advances, specifically the development of massive parallel sequencing, will modify the care of patients with malignant diseases. Pathology, therefore, has returned in the very center of interdisciplinary patient care. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670263     DOI: 10.1055/s-0033-1343106

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  6 in total

1.  [Pathological assessment of bone sarcomas].

Authors:  G Jundt; D Baumhoer
Journal:  Unfallchirurg       Date:  2014-06       Impact factor: 1.000

Review 2.  [Molecular diagnostics of non-small cell lung cancer: New markers and technologies].

Authors:  A Warth; V Endris; M Kriegsmann; A Stenzinger; R Penzel; N Pfarr; W Weichert
Journal:  Pathologe       Date:  2015-03       Impact factor: 1.011

Review 3.  [Novel morphological and molecular aspects of lung cancer].

Authors:  A Warth; A Stenzinger; W Weichert
Journal:  Pathologe       Date:  2013-09       Impact factor: 1.011

Review 4.  [The role of pathology in the diagnostics of CUP syndrome].

Authors:  A Stenzinger; M Kriegsmann; W Weichert
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

Review 5.  [Molecular pathology of lung cancer. State of the art 2014].

Authors:  A Warth; V Endris; R Penzel; W Weichert
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

Review 6.  Point-of-care diagnostic tools to detect circulating microRNAS as biomarkers of disease.

Authors:  Luis Vaca
Journal:  Sensors (Basel)       Date:  2014-05-22       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.